Fluicell AB (publ) (FLUI.ST)

SEK 0.04

(0.5%)

Eps Summary of Fluicell AB (publ)

  • Fluicell AB (publ)'s latest annual eps in 2023 was -0.24 SEK , up 25.0% from previous year.
  • Fluicell AB (publ)'s latest quarterly eps in 2024 Q2 was -0.01 SEK , up 44.31% from previous quarter.
  • Fluicell AB (publ) reported an annual eps of -0.32 SEK in 2022, up 13.51% from previous year.
  • Fluicell AB (publ) reported an annual eps of -0.37 SEK in 2021, down -12.12% from previous year.
  • Fluicell AB (publ) reported a quarterly eps of -0.01 SEK for 2024 Q2, up 44.31% from previous quarter.
  • Fluicell AB (publ) reported a quarterly eps of -0.05 SEK for 2023 Q3, up 19.13% from previous quarter.

Annual Eps Chart of Fluicell AB (publ) (2023 - 2014)

Historical Annual Eps of Fluicell AB (publ) (2023 - 2014)

Year Eps Eps Growth
2023 -0.24 SEK 25.0%
2022 -0.32 SEK 13.51%
2021 -0.37 SEK -12.12%
2020 -0.33 SEK 36.54%
2019 -0.52 SEK 70.45%
2018 -1.76 SEK -60.0%
2017 -1.10 SEK -50.68%
2016 -0.73 SEK 36.8%
2015 -1.16 SEK -129.62%
2014 -0.50 SEK 0.0%

Peer Eps Comparison of Fluicell AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 56.364%
Ziccum AB (publ) -1.54 SEK 84.416%
Modus Therapeutics Holding AB (publ) -1.01 SEK 76.238%
BioArctic AB (publ) 2.60 SEK 109.231%
Sprint Bioscience AB (publ) -0.01 SEK -3709.524%
Mendus AB (publ) -4.40 SEK 94.545%
Genovis AB (publ.) 0.94 SEK 125.532%
Intervacc AB (publ) -1.69 SEK 85.799%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -9.091%
Active Biotech AB (publ) -0.17 SEK -41.176%
Magle Chemoswed Holding AB (publ) 1.13 SEK 121.239%
Bio-Works Technologies AB (publ) -1.57 SEK 84.713%
Aptahem AB (publ) -0.05 SEK -396.894%
Vicore Pharma Holding AB (publ) -3.22 SEK 92.547%
Kancera AB (publ) -0.80 SEK 70.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 97.588%
Saniona AB (publ) -1.29 SEK 81.395%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -26.316%
Biovica International AB (publ) -2.14 SEK 88.785%
Spago Nanomedical AB (publ) -0.43 SEK 44.186%
AcouSort AB (publ) -1.29 SEK 81.395%
Xintela AB (publ) -0.13 SEK -84.615%
Abliva AB (publ) -0.09 SEK -165.487%
Egetis Therapeutics AB (publ) -1.27 SEK 81.102%
Karolinska Development AB (publ) 0.02 SEK 1300.0%
OncoZenge AB (publ) -1.36 SEK 82.353%
Amniotics AB (publ) -0.01 SEK -2081.818%
2cureX AB (publ) -1.85 SEK 87.027%
CombiGene AB (publ) -1.80 SEK 86.667%
Asarina Pharma AB (publ) -0.57 SEK 57.895%
Calliditas Therapeutics AB (publ) -8.69 SEK 97.238%
Camurus AB (publ) 7.78 SEK 103.085%
Corline Biomedical AB -0.08 SEK -185.036%
IRLAB Therapeutics AB (publ) -3.43 SEK 93.003%
Isofol Medical AB (publ) -0.23 SEK -4.348%
I-Tech AB 1.70 SEK 114.118%
Hansa Biopharma AB (publ) -15.83 SEK 98.484%
Cyxone AB (publ) -0.22 SEK -9.091%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 87.879%
Biosergen AB -0.60 SEK 60.0%
Cantargia AB (publ) -1.65 SEK 85.455%
NextCell Pharma AB -1.03 SEK 76.699%
Xspray Pharma AB (publ) -6.76 SEK 96.45%
Elicera Therapeutics AB (publ) -0.83 SEK 71.084%
Nanologica AB (publ) -2.05 SEK 88.293%
SynAct Pharma AB -6.64 SEK 96.386%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 7.692%
Stayble Therapeutics AB (publ) -0.92 SEK 73.913%
LIDDS AB (publ) -0.63 SEK 61.905%
Lipum AB (publ) -4.45 SEK 94.607%
BioInvent International AB (publ) -5.02 SEK 95.219%
Alzinova AB (publ) -0.41 SEK 41.463%
Oncopeptides AB (publ) -1.96 SEK 87.755%
Pila Pharma AB (publ) -0.47 SEK 48.936%
Guard Therapeutics International AB (publ) -11.26 SEK 97.869%
Scandinavian ChemoTech AB (publ) -1.13 SEK 78.761%
Simris Alg AB (publ) -0.16 SEK -50.0%
Diamyd Medical AB (publ) -1.60 SEK 85.0%
Xbrane Biopharma AB (publ) -1.27 SEK 81.102%
Ascelia Pharma AB (publ) -3.24 SEK 92.593%
Diagonal Bio AB (publ) -0.32 SEK 25.0%